Pneumonia caused by the bacterium Staphylococcus aureus is one of the most dangerous infections that can occur in hospital.

Palvella Therapeutics, Inc. (Nasdaq: PVLA) will take center stage at the 15th World Congress of Pediatric Dermatology in ...

IDEAYA Biosciences, Inc.’s IDYA share price has surged by 10.70%, which has investors questioning if this is right time to sell.

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...

The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ADC (R&D code: 7MW3711) has been approved by the NMPA to enter Phase Ib/II ...

Initial results from the ongoing trial saw one patient achieving a complete response in the trial combining Tovecimig with ...

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...

The WHO’s new reports on invasive fungal infections highlight the urgent need for global action to address the critical shortages in antifungal treatments and diagnostics.

YCT-529, a hormone-free male birth control pill, has shown high effectiveness in animals and is now in human trials, marking ...

Winrevair (sotatercept-csrk), compared to placebo, reduced the risk of all-cause death, lung transplantation, and hospitalization.